How effective is Prevnar 13?

Advertisement
Advertisement
Overall, Prevnar 13 (pneumococcal conjugate vaccine) is highly effective in preventing S. pneumoniae infection. Clinical and post-marketing statistics indicate that Prevnar's efficacy in preventing S. pneumoniae infection is 97% for the serotypes contained in the vaccine, and 89% against all other strains of S. pneumoniae. This efficacy rate is much higher than the 60%-70% range indicated for the polysaccharide version of the vaccine. Children with compromised immunity also seem to respond well to Prevnar 13.

Continue Learning about Vaccine

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.